Search Result "Ridaforolimus"
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 151-162
Author(s): Sylvia S. Gayle, Samuel L.M. Arnold, Ruth M. ORegan, Rita Nahta
Structural Aspects of mTOR Inhibitors: Search for Potential Compounds
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 0 Year: 2021 Page: 1-19
Author(s): Kamalpreet Kaur,Arjun Anant,Vivek Asati
Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 1 Year: 2011 Page: 24-35
Author(s): Aruni S. Arachchige Don, X. F. Steven Zheng
Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 175-187
Author(s): Xiaobei Zhang, Xi-ru Li, Jin Zhang
Targeting mTOR Signaling Pathway in Ovarian Cancer
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2960-2968
Author(s): S. Mabuchi, T. Hisamatsu, T. Kimura
Editorial (Hot Topic: Targeted Therapies in the Treatment of Breast Cancer and Localized Sarcomas)
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 5 Year: 2013 Page: 593-595
Author(s): F. Lumachi
Targeting mTOR Pathways in Human Malignancies
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2766-2777
Author(s): Angelica Fasolo,Cristiana Sessa
Pharmacological Strategies to Overcome HER2 Cross-Talk and Trastuzumab Resistance
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 1065-1075
Author(s): R. Nahta
Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 26 Year: 2014 Page: 3070-3080
Author(s): Jiezhong Chen,Kong-Nan Zhao,Rui Li,Renfu Shao,Chen Chen
Novel Therapeutic Approaches in Pancreatic Cancer Based on Genomic Alterations
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 17 Year: 2012 Page: 2452-2463
Author(s): Shinichi Yachida